伦敦生物技术初创公司Baseimmune近日宣布,其在A轮融资中成功筹集了1130万美元(约900万英镑)的资金,用于进一步发展其利用人工智能设计和开发疫苗的创新技术平台。此次融资超额认购,彰显了投资者对Baseimmune技术潜力的强烈信心。参与本轮投资的包括MSD Global Health Innovation Fund、IQ Capital等知名投资机构,以及早期支持者Hoxton Ventures、Creator Fund、Beast Ventures和Maki.vc。

Baseimmune公司致力于通过先进的机器学习算法简化疫苗设计过程,以更高效的方式应对全球公共卫生挑战。此次募集的资金将加速其研发进程,推动其平台技术的商业化,并可能为未来的疫苗研发开启新的可能。Baseimmune的突破性方法不仅可能改变疫苗设计的现状,还可能对全球疾病预防策略产生深远影响。

此次融资的成功,不仅是对Baseimmune技术的认可,也是对人工智能在医疗健康领域应用前景的一次肯定。随着全球对公共卫生问题的重视度不断提升,Baseimmune的解决方案有望在未来的传染病防控中发挥关键作用。

英语如下:

**News Title:** “London-based Biotech Company Baseimmune Raises $11.3M in Funding, AI Vaccine Design Platform Garners Attention”

**Keywords:** Baseimmune, Series A Funding, Vaccine Design

**News Content:** London-based biotech startup Baseimmune recently announced that it has successfully raised $11.3 million (approximately £9 million) in its Series A funding round, which will be allocated to further develop its innovative technology platform for designing and developing vaccines using artificial intelligence. The oversubscribed round reflects strong investor confidence in Baseimmune’s technological potential. The round was joined by prominent investors, including MSD Global Health Innovation Fund, IQ Capital, along with early backers Hoxton Ventures, Creator Fund, Beast Ventures, and Maki.vc.

Baseimmune is dedicated to simplifying the vaccine design process through advanced machine learning algorithms, enabling a more efficient response to global public health challenges. The funds raised will expedite the company’s research and development, propel the commercialization of its platform technology, and potentially open new avenues for future vaccine development. The company’s groundbreaking approach could not only revolutionize vaccine design but also have a profound impact on global disease prevention strategies.

The successful funding round not only validates Baseimmune’s technology but also underscores the promising future of AI applications in the healthcare sector. As global attention to public health issues intensifies, Baseimmune’s solutions are poised to play a critical role in future infectious disease control.

【来源】https://www.maginative.com/article/baseimmune-closes-11-3m-series-a-to-accelerate-ai-designed-vaccines/

Views: 1

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注